Documents to download

The Access to Medical Treatments (Innovation) Bill is a private member’s bill introduced by Chris Heaton-Harris (Conservative MP for Daventry) and sponsored in the House of Lords by Lord Saatchi (Conservative). The Bill completed its House of Commons stages on 29 January 2016 and received its first reading in the House of Lords on 1 February 2016. It is expected to receive its second reading in the House of Lords on 26 February 2016.  

The purpose of the Bill is to promote access to innovative medical treatments by providing for the establishment of a database of innovative medical treatments, and access to that database. When it was introduced in the House of Commons, the Bill also contained two clauses concerning medical negligence which set out the steps a doctor would need to take in order to show that he or she has acted responsibly in giving innovative treatment.  These clauses were removed during report stage in the House of Commons.  These two clauses were largely the same as those contained in the Medical Innovation Bill [HL], which was introduced by Lord Saatchi in the House of Lords on 8 June 2015 and has yet to receive a second reading.


Documents to download

Related posts

  • Smoke-free legislation: The UK and New Zealand

    During the 2023–24 session, the UK government introduced legislation to raise the age each year at which someone can legally buy tobacco products. This was similar to measures introduced in New Zealand which were recently reversed. This briefing looks at developments in New Zealand and how they have informed the debate on the UK government’s proposals.

    Smoke-free legislation: The UK and New Zealand
  • Infected blood scandal: Background, impacts, interim compensation and inquiry outcomes

    Between 1970 and the early 1990s, more than 30,000 NHS patients were given blood transfusions, or treatments which used blood products, contaminated with hepatitis C or HIV. Over 3,000 people have died as a result, and thousands live with ongoing health conditions. The infected blood inquiry has reported, calling for a range of measures, including immediate compensation, public memorials, and for lessons to be learned in medicine, government and the civil service.

    Infected blood scandal: Background, impacts, interim compensation and inquiry outcomes
  • Eating less sugar: Reformulating food and drink products and government policy

    Too much sugar in diets can contribute to health issues. Reformulating products, or changing how much sugar is in what people normally eat and drink, means the public do not have to change their habits to eat more healthily. Recent governments have introduced measures to decrease the public’s consumption of sugar, as well as salt and fat. However, some organisations have encouraged the government to go further by creating more mandatory schemes and levies for industry.

    Eating less sugar: Reformulating food and drink products and government policy